Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status-Reference-Cited by-同舟云学术

Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status

Published:2023-10 Issue:10 Volume:11 Page:1380-1393
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Peikert Alexander^ORCID,Goyal Parag^ORCID,Vaduganathan Muthiah,Claggett Brian L.,Kulac Ian J.,Miao Zi Michael,Vardeny Orly,Kosiborod Mikhail N.,Desai Akshay S.,Jhund Pardeep S.,Lam Carolyn S.P.,Inzucchi Silvio E.,Martinez Felipe A.,de Boer Rudolf A.^ORCID,Hernandez Adrian F.,Shah Sanjiv J.,Petersson Magnus,Langkilde Anna Maria,McMurray John J.V.^ORCID,Solomon Scott D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Heart failure with preserved ejection fraction in perspective;Pfeffer;Circ Res,2019

2. Epidemiology of heart failure with preserved ejection fraction;Dunlay;Nat Rev Cardiol,2017

3. Polypharmacy in older adults hospitalized for heart failure;Unlu;Circ Heart Fail,2020

4. Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care;Baron-Franco;Br J Gen Pract,2017

5. Complex and potentially harmful medication patterns in heart failure with preserved ejection fraction;Brinker;Am J Med,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cause-Specific Health Care Costs Following Hospitalization for Heart Failure and Cost Offset With SGLT2i Therapy;JACC: Heart Failure;2024-08

2. Heart failure with preserved ejection fraction therapy: combining sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists;European Heart Journal;2024-07-10

3. Pharmacological and Non-Pharmacological Advancements in Heart Failure Treatment;Reviews in Cardiovascular Medicine;2024-06-25

4. Guideline‐directed medical therapy in patients with heart failure with preserved ejection fraction and polypharmacy: Do not be afraid;European Journal of Heart Failure;2024-05

5. Effects of sacubitril/valsartan according to polypharmacy status in PARAGON‐HF;European Journal of Heart Failure;2024-04-08